Results 81 to 90 of about 6,033 (178)
Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?
Hypertension is one of the most common chronic clinical problems encountered by physicians. The prevalence of resistant hypertension is estimated at 9% in the US.
Ahmad Al-Fakhouri +3 more
doaj +1 more source
Renal Sympathetic Denervation in Patients with Aortic Dissection
BackgroundWe report on feasibility, safety, and mid‐term outcomes of renal sympathetic denervation (RSD) in hypertensive patients after endovascular treatment for aortic dissection.MethodsSix patients were subjected to RSD after receiving endovascular treatment for complicated aortic dissection.
Dimitar, Divchev +3 more
openaire +2 more sources
Summary: Neurohormonal overactivation plays an important role in pulmonary hypertension (PH). In this context, renal denervation, which aims to inhibit the neurohormonal systems, may be a promising adjunct therapy in PH.
Denielli da Silva Gonçalves Bos, MSc +12 more
doaj +1 more source
Association between renal sympathetic denervation and arterial stiffness: the ASORAS study. [PDF]
Zeijen VJM +9 more
europepmc +1 more source
Aim: to determine whether the renal sympathetic – nerve ablation method is more effective compared to multiple anti – hypertensive drug among patients with resistant hypertension. Methods: a search was conducted on PubMed.
Minarma Siagian +5 more
doaj +2 more sources
Unilateral renal atrophy 4 years after renal sympathetic denervation: a case report. [PDF]
Zeijen VJM +3 more
europepmc +1 more source
Assessment of arterial stiffness to predict blood pressure response to renal sympathetic denervation. [PDF]
Fengler K +11 more
europepmc +1 more source
Long-term follow-up of patients undergoing renal sympathetic denervation. [PDF]
Zeijen VJM +7 more
europepmc +1 more source

